BRCA2 and Familial prostate cancer: Consistently, the variant segregates with a prostate cancer case, sustaining the observation that BRCA2 variants are predominantly associated with increased risks of breast and prostate cancers (Lecarpentier et al., 2017) and less with colon cancer.